Cornerstone Wealth Management’s Sprott Physical Silver Trust PSLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-17,123
Closed -$143K 519
2023
Q1
$143K Buy
+17,123
New +$132K 0.01% 459
2022
Q3
$86K Sell
13,023
-150
-1% -$995 0.01% 429
2022
Q2
$91K Hold
13,173
0.01% 435
2022
Q1
$116K Buy
13,173
+1,250
+10% +$10.4K 0.01% 454
2021
Q4
$96K Buy
11,923
+670
+6% +$5.45K 0.01% 493
2021
Q3
$86K Buy
+11,253
New +$95.8K 0.01% 448
2018
Q4
Sell
-86,488
Closed -$13.5M 947
2018
Q3
$13.5M Buy
86,488
+54,796
+173% +$298K 0.17% 135
2018
Q2
$5.46M Buy
+31,692
New +$193K 0.06% 296
2017
Q4
Sell
-13,535
Closed -$86K 419
2017
Q3
$86K Sell
13,535
-10
-0.1% -$64 0.02% 385
2017
Q2
$82K Sell
13,545
-1,419
-9% -$9.26K 0.02% 376
2017
Q1
$100K Sell
14,964
-1,334
-8% -$8.85K 0.02% 340
2016
Q4
$102K Sell
16,298
-6,936
-30% -$45.5K 0.03% 278
2016
Q3
$161K Buy
+23,234
New +$175K 0.06% 265

Other funds holding PSLV

Cornerstone Wealth Management's PSLV Position: Q2 2023 in Review

Cornerstone Wealth Management sold out of Sprott Physical Silver Trust (PSLV) in Q2 2023, closing a stake of 17,123 shares — an estimated $143K sold.

Cornerstone Wealth Management first reported a position in PSLV in Q3 2016 and held it in 13 quarters. The position peaked at $13.5M in Q3 2018. 309 funds tracked by Wall St. Rank hold PSLV as of Q2 2023.

  • Cornerstone Wealth Management reported no remaining Sprott Physical Silver Trust position as of Q2 2023 after selling out during the quarter.
  • Cornerstone Wealth Management sold 17,123 Sprott Physical Silver Trust shares in Q2 2023, an estimated $143K.
  • Cornerstone Wealth Management first reported a position in Sprott Physical Silver Trust in Q3 2016 and held it in 13 quarters.
  • Cornerstone Wealth Management's Sprott Physical Silver Trust position peaked at $13.5M in Q3 2018.
  • 309 funds tracked by Wall St. Rank held Sprott Physical Silver Trust as of Q2 2023.

Based on Cornerstone Wealth Management's 13F filing for Q2 2023, filed 14 Jul 2023.